Emerging Immune‐Based Therapeutic Strategies in Hepatocellular Carcinoma
ABSTRACT Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide despite recent advances in systemic therapy. The introduction of immune checkpoint inhibitors has substantially expanded treatment options for advanced disease; however, durable responses are observed only in a subset of patients.
Janine Kah +2 more
wiley +1 more source
Impaired CD47–SIRPα Interactions in Antigen‐Priming Results in Defects in Proliferation In Vivo
Anu Autio +6 more
openaire +1 more source
Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. [PDF]
Lustig M +29 more
europepmc +1 more source
Myeloid Malignancies Beyond the Cell: Targeting the Tumour Microenvironment with Next-Generation Immunotherapies. [PDF]
Amirian N +5 more
europepmc +1 more source
Irinotecan Modulates Immune Checkpoints in Neuroblastoma. [PDF]
Lapidus T +4 more
europepmc +1 more source
Spatial immune atlas of breast cancer brain metastasis reveals CD163<sup>+</sup> macrophage reprogramming associated with immune escape. [PDF]
Zhu J +6 more
europepmc +1 more source
The LAV-BPIFB4-Platelet-CD47 Axis: A Novel Mechanism Associated With Immune Resilience in Longevity. [PDF]
Ciaglia E +13 more
europepmc +1 more source
Analysis of Prognostic Significance of CD47 Expression in Newly Diagnosed Large B Cell Lymphoma. [PDF]
Markovic O +8 more
europepmc +1 more source

